506 related articles for article (PubMed ID: 35134099)
21. What should be measured and reported in clinical trials for the treatment of patients with acute pancreatitis? A study protocol for establishing a core outcome set.
Shen Y; Hu C; Li L; Chen Z; Chen W; Lin Z; Zhu P; Tan Q; Huang W; Sun X; Deng L; Xia Q
BMJ Open; 2023 Dec; 13(12):e075859. PubMed ID: 38070929
[TBL] [Abstract][Full Text] [Related]
22. Developing a core outcome set for the treatment of pregnant women with pregestational diabetes-a study protocol.
Kgosidialwa O; Bogdanet D; Egan A; O'Shea PM; Biesty L; Devane D; Dunne F;
Trials; 2020 Dec; 21(1):1017. PubMed ID: 33308263
[TBL] [Abstract][Full Text] [Related]
23. Protocol for the development of a core outcome set for lateral elbow tendinopathy (COS-LET).
Bateman M; Evans JP; Vuvan V; Jones V; Watts AC; Phadnis J; Bisset L; Vicenzino B
Trials; 2021 May; 22(1):339. PubMed ID: 33971941
[TBL] [Abstract][Full Text] [Related]
24. IMMPACT-recommended outcome measures and tools of assessment in burning mouth syndrome RCTs: an international Delphi survey protocol.
Carey B; Farag AM; Nasri-Heir C; Klasser GD; Ariyawardana A; Chmieliauskaite M; Sardella A; Carlson CR; Miller CS; Mejia L; O'Neill FE; Albuquerque R
Trials; 2020 Aug; 21(1):711. PubMed ID: 32787910
[TBL] [Abstract][Full Text] [Related]
25. Protocol for the development of an international Core Outcome Set for treatment trials in adults with epilepsy: the EPilepsy outcome Set for Effectiveness Trials Project (EPSET).
Mitchell JW; Noble A; Baker G; Batchelor R; Brigo F; Christensen J; French J; Gil-Nagel A; Guekht A; Jette N; Kälviäinen R; Leach JP; Maguire M; O'Brien T; Rosenow F; Ryvlin P; Tittensor P; Tripathi M; Trinka E; Wiebe S; Williamson PR; Marson T
Trials; 2022 Nov; 23(1):943. PubMed ID: 36397081
[TBL] [Abstract][Full Text] [Related]
26. Study protocol to develop a core outcome set for thyroid dysfunction to bridge the unmet needs of patient-centred care.
Ooi CP; Yusof Khan AHK; Abdul Manaf R; Mustafa N; Sukor N; Williamson PR; Kamaruddin NA
BMJ Open; 2021 Jul; 11(7):e050231. PubMed ID: 34321306
[TBL] [Abstract][Full Text] [Related]
27. Development of a Core Outcome Set for Studies on Cardiac Disease in Pregnancy (COSCarP): a study protocol.
D'Souza R; Hall C; Sermer M; Siu S; Silversides C
Trials; 2020 Mar; 21(1):300. PubMed ID: 32228655
[TBL] [Abstract][Full Text] [Related]
28. International development and implementation of a core measurement set for research and audit studies in implant-based breast reconstruction: a study protocol.
Potter S; Davies C; Holcombe C; Weiler-Mithoff E; Skillman J; Vidya R; Masannat Y; Weber W; Heil J; Wilson S; Thrush S; Whisker L; Blazeby J; Metcalfe C; Avery K
BMJ Open; 2020 Jan; 10(1):e035505. PubMed ID: 31964677
[TBL] [Abstract][Full Text] [Related]
29. The outcomes of Perthes' disease of the hip: a study protocol for the development of a core outcome set.
Leo DG; Leong WY; Gambling T; Long A; Murphy R; Jones H; Perry DC
Trials; 2018 Jul; 19(1):374. PubMed ID: 30005667
[TBL] [Abstract][Full Text] [Related]
30. Development of a core outcome set for clinical trials in basal cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
Schlessinger DI; Iyengar S; Yanes AF; Lazaroff JM; Godinez-Puig V; Chen BR; Kurta AO; Henley JK; Chiren SG; Furlan KC; Schmitt J; Deckert S; Poon E; Sobanko JF; Cartee TV; Alam M; Maher IA
Trials; 2017 Oct; 18(1):490. PubMed ID: 29061190
[TBL] [Abstract][Full Text] [Related]
31. Development of a Core Outcome Set for Dysphagia Interventions in Parkinson's disease (COS-DIP): study protocol.
Hirschwald J; Duncan S; Warnecke T; Boyle G; Regan J; Walshe M
BMJ Open; 2024 Feb; 14(2):e076350. PubMed ID: 38341204
[TBL] [Abstract][Full Text] [Related]
32. The development of a faecal incontinence core outcome set: an international Delphi study protocol.
Assmann S; Keszthelyi D; Kleijnen J; Kimman M; Anastasiou F; Bradshaw E; Carrington E; Chiarioni G; Maeda Y; Muris J; Pohl D; Rydningen M; Vaizey C; Breukink S
Int J Colorectal Dis; 2021 Mar; 36(3):617-622. PubMed ID: 33532899
[TBL] [Abstract][Full Text] [Related]
33. Core outcomes in periodontal trials: study protocol for core outcome set development.
Lamont TJ; Clarkson JE; Ricketts DNJ; Heasman PA; Ramsay CR
Trials; 2017 Sep; 18(1):436. PubMed ID: 28931440
[TBL] [Abstract][Full Text] [Related]
34. Development of a core outcome set for groin hernia trials: a study protocol.
Gram-Hanssen A; Rosenberg J
Dan Med J; 2021 Nov; 68(12):. PubMed ID: 34851252
[TBL] [Abstract][Full Text] [Related]
35. Engaging pregnant individuals and healthcare professionals in an international mixed methods study to develop a core outcome set for studies on placenta accreta spectrum disorder (COPAS): a study protocol.
O'Rinn SE; Barrett JFR; Parsons JA; Kingdom JC; D'Souza R
BMJ Open; 2023 Apr; 13(4):e060699. PubMed ID: 37185194
[TBL] [Abstract][Full Text] [Related]
36. Developing a core outcome set for people living with dementia at home in their neighbourhoods and communities: study protocol for use in the evaluation of non-pharmacological community-based health and social care interventions.
Harding AJE; Morbey H; Ahmed F; Opdebeeck C; Wang YY; Williamson P; Swarbrick C; Leroi I; Challis D; Davies L; Reeves D; Holland F; Hann M; Hellström I; Hydén LC; Burns A; Keady J; Reilly S
Trials; 2018 Apr; 19(1):247. PubMed ID: 29690920
[TBL] [Abstract][Full Text] [Related]
37. Development of a Core outcome set for fetal Myelomeningocele (COSMiC): study protocol.
Altoukhi S; Whitehead CL; Ryan G; Deprest J; Joyeux L; Gallagher K; Drake J; Church P; Horn D; Diambomba Y; Carvalho JCA; Van Mieghem T
Trials; 2020 Aug; 21(1):732. PubMed ID: 32825852
[TBL] [Abstract][Full Text] [Related]
38. Protocol for the development of a core outcome set for reporting outcomes of management of velopharyngeal dysfunction.
de Blacam C; Baylis AL; Kirschner RE; Smith SM; Sell D; Sie KCY; Harris HE; Orr DJA
BMJ Open; 2020 Aug; 10(8):e036824. PubMed ID: 32792441
[TBL] [Abstract][Full Text] [Related]
39. Protocol for the development of a core outcome set for clinical trials in primary sclerosing cholangitis.
Hussain N; Ma C; Hirschfield G; Walmsley M; Hanford P; Vesterhus M; Kowdley K; Bergquist A; Ponsioen C; Levy C; Assis D; Schramm C; Bowlus C; Trauner M; Aiyegbusi OL; Jairath V; Trivedi PJ
BMJ Open; 2024 Jun; 14(6):e080143. PubMed ID: 38926149
[TBL] [Abstract][Full Text] [Related]
40. Measuring communication as a core outcome in aphasia trials: Results of the ROMA-2 international core outcome set development meeting.
Wallace SJ; Worrall L; Rose TA; Alyahya RSW; Babbitt E; Beeke S; de Beer C; Bose A; Bowen A; Brady MC; Breitenstein C; Bruehl S; Bryant L; Cheng BBY; Cherney LR; Conroy P; Copland DA; Croteau C; Cruice M; Dipper L; Hilari K; Howe T; Kelly H; Kiran S; Laska AC; Marshall J; Murray LL; Patterson J; Pearl G; Quinting J; Rochon E; Rose ML; Rubi-Fessen I; Sage K; Simmons-Mackie N; Visch-Brink E; Volkmer A; Webster J; Whitworth A; Dorze GL
Int J Lang Commun Disord; 2023; 58(4):1017-1028. PubMed ID: 36583427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
